Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    No additions or deletions detected; the page content remains unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:03:08.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.
    Difference
    3%
    Check dated 2025-10-06T08:11:46.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:42:50.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page is updated to revision v3.0.2 (replacing v3.0.1), and the Back to Top link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T22:28:06.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-07T19:40:28.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as a comprehensive list of publications related to biliary tract cancer and associated treatments. Notably, several terms and classifications related to cancer treatment have been removed.
    Difference
    9%
    Check dated 2025-08-31T12:34:40.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.